Oral cancer detection and imaging systems.
Oncolight oral lesion screening kit for Vista-dental.
In the US 40,000 people are diagnosed with oral cancer each year (worldwide: 640.000). The survival
rate after 5 years for people newly diagnosed with oral cancer is about 65%.
A 50% increase in the number of
new diagnoses worldwide annually of oral cancer is predicted during the next 20 years. Early detection
transforms the 5 year survival rate to more than 90%.
Vista Dental’s OncoLight Oral Lesion Screening Kit will improve early detection of oral abnormalities by reducing false positives and improving lesion visibility(sensitivity and specificity). It also will be non-staining, non-toxic, palatable, and affordable.